Calidi Biotherapeutics (CLDI) Interest Coverage Ratio (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Interest Coverage Ratio of 0.09 for Q4 2025, up 100.81% year-over-year from 0.05 in Q4 2024, and up 100.34% quarter-over-quarter from 27.43 in Q3 2025.
Calidi Biotherapeutics (CLDI) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Calidi Biotherapeutics' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 0.09 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 100.81% year-over-year to 0.09; the TTM figure through Dec 2025 stood at 0.73 (up 101.38% YoY), while the FY2025 annual figure was 0.59, up 20.13% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 0.09, up from 27.43 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 16.79 in Q4 2023, with the low at 240.9 in Q3 2022.
- The 4-year median for Interest Coverage Ratio is 8.8 (2024), against an average of 24.15.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio surged 373.21% in 2023, then plunged 573.73% in 2024.
- Calidi Biotherapeutics' Interest Coverage Ratio stood at 6.14 in 2022, then soared by 373.21% to 16.79 in 2023, then plunged by 167.37% to 11.31 in 2024, then jumped by 100.81% to 0.09 in 2025.
- Business Quant data shows CLDI's Interest Coverage Ratio at 0.09 in Q4 2025, 27.43 in Q3 2025, and 0.28 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | -143.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.93 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | -27.43 |
| Jun 30, 2025 | -0.28 |
| Mar 31, 2025 | -7.92 |
| Dec 31, 2024 | -11.31 |
| Sep 30, 2024 | -10.49 |
| Jun 30, 2024 | -9.68 |
| Mar 31, 2024 | -1.49 |
| Dec 31, 2023 | 16.79 |
| Sep 30, 2023 | -1.56 |
| Jun 30, 2023 | -21.79 |
| Mar 31, 2023 | -15.97 |
| Dec 31, 2022 | -6.14 |
| Sep 30, 2022 | -240.90 |